Brian A Fox

This inventor holds 49 USPTO granted patents and 8 published patent applications, plus 4 CIPO patents and 8 EPO patents, primarily in Cytokine Proteins. Top assignee: Zymogenetics, Inc.. Active years: 1998-2020.

USPTO Granted Patents = 49 (Patent Applications = 8)

% Patents Active = 55.1

CIPO Patents = 4 (Patent Applications = 5)

EPO Patents = 8 (Patent Applications = 6)

Average Co-Inventor Count = 3.7

ph-index = 13

Forward Citations = 581(Granted Patents)

Location History:

Wethersfield, CT (US) (1998 - 1999)
Glendale, AZ (US) (2017)
Seattle, WA (US) (2004 - 2020)

Company Filing History:

46 out of 723

Zymogenetics, Inc.

patents

where one patent can have more than one assignee

Years Active: 1998-2020

Loading Chart...

Areas of Expertise:

Cytokine Protein Family

Soluble IL-20 Receptor

Trimerizing Polypeptides

Dimeric Fusion Proteins

Anti-zB7H6 Antibody

Interferon-like Protein ZCYTO21

B7 Family Member

Ztnfr14

49 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10570187 - Soluble hybrid Fcγ receptors and related methods (2020-02-25),

2. 10005837 - B7 family member zB7H6 and related compositions and methods (2018-06-26),

3. D788543 - Cooler lid (2017-06-06),

4. 9663566 - Soluble hybrid Fcγ receptors and related methods (2017-05-30),

5. 8969518 - B7 family member zB7H6 and related compositions and methods (2015-03-03),

6. 8658766 - Soluble hybrid Fcγ receptors and related methods (2014-02-25),

7. 8231866 - Cytokine protein family (2012-07-31),

8. 8217008 - Methods of treating inflammatory disease using a soluble IL-20 receptor (2012-07-10),

9. 8124065 - Cytokine Protein Family (2012-02-28),

10. 8084230 - Trimerizing polypeptides (2011-12-27),

11. 7919595 - Antibodies to interferon-like protein Zcyto21(IL29) (2011-04-05),

12. 7910313 - Cytokine protein family (2011-03-22),

13. 7858759 - Anti-zB7H6 antibody-drug conjugates (2010-12-28),

14. 7833520 - Method of using interferon-like protein ZCYTO21(IL-29) to treat hepatitis B (2010-11-16),

15. 7829076 - Method of using interferon-like potein ZCYTO20 (IL-28A) or ZCYTO22(IL-28B) to treat hepatitis B (2010-11-09),

Title: Innovator Spotlight - Brian A. Fox: Pioneering Discoveries in Biotechnology

Introduction:

Brian A. Fox, a distinguished inventor based in Seattle, WA, is renowned for his groundbreaking work in biotechnology. With an impressive portfolio of 46 patents, he continues to push the boundaries of scientific innovation.

Latest Patents:

Among his latest patents is the development of soluble hybrid Fcγ receptors, revolutionizing the treatment of IgG-mediated and immune complex-mediated inflammation. Additionally, Brian A. Fox has unveiled the discovery of zB7H6, a novel member of the B7 family, offering new avenues for modulating NK cell activity and combating zB7H6-expressing cells with innovative antibody-drug conjugates.

Career Highlights:

Currently employed at ZymoGenetics, Inc., Brian A. Fox has been instrumental in driving research and development initiatives within the company. His contributions have significantly impacted the field of biotechnology, garnering recognition for his commitment to advancing healthcare solutions.

Collaborations:

Brian A. Fox has had the privilege of collaborating with esteemed colleagues such as Paul O. Sheppard and Scott R. Presnell. Together, they have synergized their expertise to pioneer transformative technologies and bring about novel therapeutic interventions.

Conclusion:

In conclusion, Brian A. Fox stands as a visionary inventor whose inventive prowess has reshaped the landscape of biotechnology. Through his relentless pursuit of innovation and collaboration with industry peers, he continues to propel the field forward, leaving an indelible mark on the realm of scientific discovery.